Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.
Saved in:
| Title: | Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors. |
|---|---|
| Authors: | Matter-Walstra K; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland. klazien.matter@unibas.ch.; SAKK Coordinating Centre, Bern, Switzerland. klazien.matter@unibas.ch., Braun R; Department Dermatology, University Hospital Zürich, Zürich, Switzerland., Kolb C; SAKK Coordinating Centre, Bern, Switzerland., Ademi Z; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland., Dummer R; Department Dermatology, University Hospital Zürich, Zürich, Switzerland., Pestalozzi BC; SAKK Coordinating Centre, Bern, Switzerland.; Department Oncology, University Hospital Zürich, Zürich, Switzerland., Schwenkglenks M; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland. |
| Source: | The British journal of dermatology [Br J Dermatol] 2016 Feb; Vol. 174 (2), pp. 463. Date of Electronic Publication: 2016 Jan 20. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
